This report provides comprehensive information on the therapeutic development for Tardive Dyskinesia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases

1. Hexa Reports
Market Research Reports and Insightful Company Profiles
Tardive Dyskinesia Industry 2015 Market Share, Size, Industry
Profile, Market Prize, Forecast and Overview
Global Markets Direct's, 'Tardive Dyskinesia - Pipeline Review, H2 2015', provides an overview of the
Tardive Dyskinesia's therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Tardive Dyskinesia,
complete with comparative analysis at various stages, therapeutics assessment by drug target,
mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates,
and featured news and press releases. It also reviews key players involved in the therapeutic
development for Tardive Dyskinesia and special features on late-stage and discontinued projects.
Browse Detail Report With TOC @ http://www.hexareports.com/report/tardive-dyskinesia-pipeline-
review-h2-2015/details
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications. The report is built using data and information sourced from Global
Markets Direct's proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and industry-specific third
party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the
report undergoes periodic updation following a stringent set of processes that ensures that all the
profiles are updated with the latest set of information. Additionally, processes including live news &
deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent
developments are captured on a real time basis.

2. Hexa Reports
Market Research Reports and Insightful Company Profiles
The report enhances decision making capabilities and help to create effective counter strategies to gain
competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and
relevance of data for the indicated disease.
Scope
 The report provides a snapshot of the global therapeutic landscape of Primary Tardive
Dyskinesia
 The report reviews key pipeline products under drug profile section which includes, product
description, MoA and R&D brief, licensing and collaboration details & other developmental
activities
 The report reviews key players involved in the therapeutics development for Primary Tardive
Dyskinesiaand enlists all their major and minor projects
 The report summarizes all the dormant and discontinued pipeline projects
 A review of the Primary Tardive Dyskinesiaproducts under development by companies and
universities/research institutes based on information derived from company and industry
 specific sources Pipeline products coverage based on various stages of development ranging
from pre-registration till discovery and undisclosed stages
 A detailed assessment of monotherapy and combination therapy pipeline projects
 Coverage of the Primary Tardive Dyskinesiapipeline on the basis of target, MoA, route of
administration and molecule type
 Latest news and deals relating related to pipeline products
Reasons to buy
 Provides strategically significant competitor information, analysis, and insights to formulate
effective R&D development strategies
 Identify emerging players with potentially strong product portfolio and create effective counter
 strategies to gain competitive advantage
 Develop strategic initiatives by understanding the focus areas of leading companies
 Identify and understand important and diverse types of therapeutics under development for
Primary Tardive Dyskinesia
 Plan mergers and acquisitions effectively by identifying key players of the most promising
pipeline
 Devise corrective measures for pipeline projects by understanding Primary Tardive
Dyskinesiapipeline depth and focus of Indication therapeutics
 Develop and design in-licensing and out-licensing strategies by identifying prospective partners
with the most attractive projects to enhance and expand business potential and Scope

3. Hexa Reports
Market Research Reports and Insightful Company Profiles
 Modify the therapeutic portfolio by identifying discontinued projects and understanding the
factors that drove them from pipeline
Request A Sample copy of This Report @ http://www.hexareports.com/sample/46623
Table Of Content
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Tardive Dyskinesia Overview 6
Therapeutics Development 7
Pipeline Products for Tardive Dyskinesia - Overview 7
Pipeline Products for Tardive Dyskinesia - Comparative Analysis 8
Tardive Dyskinesia - Therapeutics under Development by Companies 9
Tardive Dyskinesia - Pipeline Products Glance 10
Late Stage Products 10
Clinical Stage Products 11
Early Stage Products 12
Tardive Dyskinesia - Products under Development by Companies 13
Tardive Dyskinesia - Companies Involved in Therapeutics Development 14
Addex Therapeutics Ltd 14
Contera Pharma ApS 15
Neurocrine Biosciences, Inc. 16
Synchroneuron Inc. 17
Teva Pharmaceutical Industries Limited 18
Tardive Dyskinesia - Therapeutics Assessment 19
Assessment by Monotherapy Products 19
Assessment by Target 20
Assessment by Mechanism of Action 22
Assessment by Route of Administration 24
Assessment by Molecule Type 25
Drug Profiles 26
acamprosate calcium SR - Drug Profile 26
Product Description 26 Mechanism of Action 26
R&D Progress 26
dipraglurant IR - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28

4. Hexa Reports
Market Research Reports and Insightful Company Profiles
Drugs for Tardive Dyskinesia - Drug Profile 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
dutetrabenazine ER - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
valbenazine - Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Tardive Dyskinesia - Recent Pipeline Updates 34
Tardive Dyskinesia - Dormant Projects 43
Tardive Dyskinesia - Product Development Milestones 44
Featured News & Press Releases 44
Browse Full Report @ http://www.hexareports.com/report/tardive-dyskinesia-pipeline-review-h2-
2015/details
About Us:
Hexa Reports is a market research and consulting organization, offering industry reports, custom
research and consulting services to a host of key industries across the globe. We offer comprehensive
business intelligence in the form of industry reports which help our clients obtain clarity about their
business environment and enable them to undertake strategic growth initiatives.
Contact Information:
Ryan Shaw
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number
1-800-489-3075
Email Us: sales@hexareports.com
Our Website: http://www.hexareports.com/